| 주제어 |
18kda
|
1
|
1
|
|
|
antianxiety drugs
|
1
|
1
|
|
|
etifoxine
|
1
|
1
|
|
|
gamma-aminobutyric
|
1
|
1
|
|
|
herniated discs
|
1
|
1
|
|
|
humantranslocatorprotein
|
1
|
1
|
|
|
molecularmechanismsofpharmaco ...
|
1
|
1
|
|
|
neurosteroids
|
1
|
1
|
|
|
nonopioidanalgesics
|
1
|
1
|
|
|
Beta-arrestin 2
|
2
|
1
|
|
|
Intracellular signaling pept ...
|
2
|
1
|
|
|
Oliceridine
|
2
|
1
|
|
|
Mu opioid receptor
|
4
|
2
|
|
|
N-desmethyltapentadol
|
2
|
1
|
|
|
Tapentadol
|
2
|
1
|
|
|
dysesthesia
|
2
|
1
|
|
|
수정된 정규화비율 방법
|
2
|
1
|
|
|
연속적 결측
|
2
|
1
|
|
|
회귀 방법
|
2
|
1
|
|
|
Knockout mice
|
3
|
1
|
|
|
Alpha adrenergic receptors
|
3
|
1
|
|
|
intravenous infusion
|
3
|
1
|
|
|
결측값 대체
|
3
|
1
|
|
|
G protein-coupled receptors
|
4
|
1
|
|
|
whole crop barley
|
4
|
1
|
|
|
adverse drug reactions
|
17
|
4
|
|
|
percutaneous discectomy
|
5
|
1
|
|
|
gabareceptors
|
6
|
1
|
|
|
poisson process
|
6
|
1
|
|
|
헤이우드케이스
|
6
|
1
|
|
|
Ligands
|
7
|
1
|
|
|
nerve regeneration
|
7
|
1
|
|
|
nefopam
|
15
|
2
|
|
|
mechanismofaction
|
8
|
1
|
|
|
modeofaction
|
8
|
1
|
|
|
nociceptive pain
|
8
|
1
|
|
|
opioid analgesics
|
9
|
1
|
|
|
청보리
|
9
|
1
|
|
|
Acute pain
|
10
|
1
|
|
|
베이지안 방법
|
10
|
1
|
|
|
addictive behavior
|
13
|
1
|
|
|
종단 자료
|
15
|
1
|
|
|
neuropathic pain
|
46
|
3
|
|
|
anticonvulsants
|
19
|
1
|
|
|
symptom assessment
|
22
|
1
|
|
|
Neuropathic pain
|
52
|
2
|
|
|
Chronic pain
|
52
|
1
|
|
|
hyperalgesia
|
58
|
1
|
|
|
postoperative pain
|
69
|
1
|
|
|
Patient safety
|
170
|
1
|
|
|
structural equation model
|
245
|
1
|
|
|
구조방정식
|
542
|
1
|
|
|
anxiety
|
752
|
1
|
|
| 계 |
|
2,237 |
61 |
|
| * 주제로 분류 되지 않은 논문건수 |
|
0 |
|
